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Abstract
Background/Aims: Digital single-operator cholangioscopy 
(dSOC) has revolutionized bile duct visualization. Interven-
tions like electrohydraulic or laser lithotripsy, inspection of 
suspicious areas, and targeted biopsies have become pos-
sible quick and easy. One main indication for dSOC remains 
the evaluation of indeterminate biliary strictures. Objective 
and Methods: We analyzed 180 consecutive dSOCs proce-
dures performed in a high-volume tertiary center to evaluate 
sensitivity, specificity as well as positive and negative predic-
tive values (PPV and NPV) for indeterminate strictures. Fur-
thermore, technical success and complications were ana-
lyzed. Results: In 92–97%, the region of interest was reached 
and successfully visualized. In 83–100%, targeted biopsies 
were obtained from the suspicious area. Only the distal bile 
duct was less successful with only 84 and 62%, respectively. 
In general, dSOC procedures were safe. Cholangitis was the 
main complication. Regarding the diagnostic accuracy of 
dSOC of indeterminate biliary strictures, we found a sensitiv-
ity of 0.87 and specificity of 0.88, over all. Within the whole 
cohort, the investigators’ assessment directly after dSOC had 
a PPV of 0.63 and a NPV of 0.97. In patients with biliary lesions 
or stenosis suspicious for malignancy, the dSOC-based vi-
sual diagnosis revealed a very high diagnostic accuracy with 
sensitivity and specificity of 1.0 (95% CI 0.86–1.0) and 0.76 
(95% CI 0.56–0.9) with a PPV of 0.77 (95% CI 0.59–0.9) and a 
high NPV of 1.0 (95% CI 0.85–1.0). Conclusions: Our study 
demonstrates that dSOC has a high diagnostic accuracy as 
well as a favorable safety profile. Therefore, dSOC should be 
discussed as standard of care during endoscopic retrograde 
cholangiography for indeterminate biliary lesions.
© 2021 The Author(s)
Published by S. Karger AG, Basel
Introduction
Endoscopic retrograde cholangiopancreatography 
(ERCP) as a standard endoscopic intervention for biliary 
diseases has been established for decades. Main indica-
tions are indeterminate biliary lesions with suspected ma-
lignancy, strictures, bile duct stones, cholangitis, and 
postsurgical complications like strictures and leakage [1–
6]. Due to the two-dimensional imaging in fluoroscopy, 
ERCP has also distinct limitations, especially for the char-
acterization of biliary strictures and the differentiation 
between inflammatory, malignant, or fibrotic pathogen-
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esis. In addition, tissue sampling by ERCP-directed 
brushing has a low sensitivity and specificity [7, 8]. Fur-
thermore, guidewire placement in complicated strictures, 
malignant stenosis, or after surgery can be difficult only 
using fluoroscopy guidance.
Transpapillar cholangioscopy allows direct visualiza-
tion of the biliary system up to biliary branches of second 
and third order. 2006 the SpyGlassTM single-operator 
cholangioscopy (SOC) (Boston Scientific Coro., Natick, 
MA, USA) has been introduced, making cholangioscopy 
widely available and feasible [9, 10]. While the first gen-
eration of SOC was quite low in visualization quality due 
to a fiber optical probe, the introduction of the digital 
high-resolution cholangioscopy SpyGlass DSTM (dSOCS) 
(Boston Scientific Coro., Natick, MA, USA) in 2015 has 
achieved much better biliary endoscopic imaging quality. 
Over the last years, some studies have demonstrated safe-
ty profile and technical accuracy [11–13]. Especially, the 
diagnostic efficacy, sensitivity, and specificity for indeter-
minate biliary lesions have been investigated in different 
studies [8, 14, 15]. These studies included tissue sampling 
under direct visualization control through the SpyGlass 
DSTM using a small biopsy forceps. Therapeutic SOC has 
been further evaluated for the treatment of difficult bili-
ary stones using electrohydraulic lithotripsy (EHL) or la-
ser lithotripsy [16] and for management of complex bili-
ary strictures [15, 17, 18].
We performed a single-center study to analyze dSOCs 
using SpyGlass DSTM at a high-volume endoscopic center 
at a university hospital specialized for hepatology, gastro-
intestinal oncology, digestive and liver surgery, including 
liver transplantation. We performed a retrospective analy-
sis of all dSOC procedures that have been performed from 
2016 till 2017 for any reason, to evaluate the accuracy of the 
cholangioscopic image-based diagnosis for the prediction 
of malignancy in strictures and suspect biliary lesions.
Furthermore, therapeutic efficacy of cholangioscopic-
assisted guidewire placement, stone destruction, and 
stricture therapy was examined. In addition, technical ef-
ficacy, safety, and complications were evaluated.
Patients and Methods
Study Design
This retrospective study was performed at the Department of 
Internal Medicine I at the University Hospital Regensburg. This 
study was approved by the local Ethics Committee of the Univer-
sity of Regensburg (No. 18-1121-104) and was performed accord-
ing the updated guidelines of good clinical practice and updated 
Declaration of Helsinki. Prior to the cholangioscopy informed 
consent for the examination was obtained from all patients.
All patients who underwent dSOC using the SpyGlass DSTM 
system at the University Hospital Regensburg between April 2016 
and December 2017 were included in a clinical database. Addi-
tional clinical data and the clinical follow-up until August 2018 
were retrieved from the clinical data information system. Patients 
with suspicious biliary lesions were routinely followed up based on 
their specific findings (biopsies with malignant histology, surgery, 
radiological imaging, or endoscopic follow-up including repetitive 
dSOC). The minimum follow-up period in the study cohort was at 
least 90 days.
Technical Aspects and Definition of Study Outcome 
Parameters
All examinations were performed by 3 highly experienced in-
vestigators with ERC cases >200/year. Endoscopic papillotomy 
was performed prior dSOCs or had been done in a previous inves-
tigation. Aspiration of biliary fluid for microbial analysis was per-
formed routinely after guidewire insertion and before massive 
contrast injection.
Papillary intubation and insertion of the cholangioscope into the 
common bile duct (CBD) were achieved directly or by guidewire as-
sistance. In general, cholangioscopy was performed before massive 
contrast injection or any other procedure in the bile ducts to reduce 
artificial findings. In all cases, the SpyGlass DSTM device was deeply 
introduced into the biliary system as far as possible, at least proximal 
of the bifurcation. Careful examination of the biliary mucosa and 
potential indeterminate strictures was performed during retraction 
of the dSOC device. Strictures were visualized and described similar 
to the recently introduced classification system for macroscopic clas-
sification of neoplastic lesions [19]. Macroscopic criteria for neoplas-
tic lesions have been introduced criteria for potential malignant le-
sions are irregular vascular patterns, ulcerations, polypoid appear-
ance, and irregular surface with/without spontaneous bleeding.
All examinations were performed under CO2 insufflation. Pro-
phylactic antibiotic treatment was not performed routinely for 
each examination but was applied for other indications such as 
dilation therapy, lithotripsy, local ablation, or incomplete drainage 
of distinct parts of the biliary tract. In case of preexisting cholan-
gitis or other infection, most patients already received antibiotic 
therapy before.
The diagnostic accuracy of the visual diagnosis of biliary lesions 
or stenosis by dSOCs using the SpyGlass DSTM system was evalu-
ated. According to the cholangioscopic imaging, each biliary lesion 
was diagnosed as a potential malignant stenosis or nonmalignant 
stenosis in the written report of each investigator. Biopsies (>6 bi-
opsies per lesion and single biopsy technique) were taken from the 
stenosis or strictures under visual guidance using the SpyBite for-
ceps (SpyBite, single-use, and 1.0 mm diameter) and directly 
rinsed into formalin for pathological examination. Successful bi-
opsy was defined as true-positive or true-negative histology.
The diagnostic accuracy (sensitivity, specificity, positive, and 
negative predictive values [PPV and NPV]) of the visual cholan-
gioscopic diagnosis was analyzed according to histopathological 
results, surgical outcomes in case of resection, or the clinical his-
tory in case of clinical follow-up (including endoscopic follow-up 
and follow-up imaging by CT scan or MRI).
In case of strictures that had not been passed by guidewire be-
fore, guidewire placement was achieved under visual control. 
Therapeutic success in case of complicated strictures or stenosis 





allowing endoscopic therapy such as balloon dilation or stent 
placement.
For EHL, the Northgate Autolith iEHL generator with a 1.9 F 
probe or the Walz EHL probe (P2,4/3000/f probe; Walz Elektron-
ik GmbH, Rohrdorf, Germany) was used. After fragmentation, 
stone clearance was achieved by using a basket or balloon catheter. 
In case of incomplete clearance, a plastic stent was inserted until 
the procedure was repeated.
The technical success of dSOC in our study was defined
 −  As the successful placement of the guidewire across the biliary 
stricture allowing subsequent balloon dilation and/or endo-
prosthesis placement;
 −  As the successful identification of a suspicious and previous 
defined region of interest (ROI) with cholangioscopic-guided 
biopsies;
 −  Successful destruction of intraluminal stones using EHL.
dSOC-associated complications were defined and extracted 
from the clinical data sheets and clinical information system. The 
following complications were defined (I) bleeding: significant 
drop of hemoglobin, hematochezia, and need for endoscopy; 
(II) cholangitis: new onset of fever, significant increase of inflam-
matory markers and liver enzymes, requiring antibiotic therapy; 
(III) pancreatitis: new onset of abdominal pain and a three-fold 
increase in serum lipase within 24–48 h after the intervention; 
(IV) perforation. No embolism occurred in our study cohort.
Statistical Analysis
Descriptive statistics including means, standard error of mean, 
and frequencies were calculated. Sensitivity, specificity, PPV, 
NPV, and accuracy were calculated for visual, cholangioscopic di-
agnosis of suspected lesions. Data analysis was performed using 
Graphpad Prism 6.0 (GraphPad Software; La Jolla, CA, USA).
Results
Patients’ Characteristics and Procedural 
Complications
180 investigations with dSOCs in 117 patients (mean 
age 64 years, range 7–97 years, male 66%, and female 
34%) were included in the analysis (see Table 1). In 4 pa-
tients, dSOCs was performed by percutaneous biliary ac-
cess after percutaneous transhepatic biliary drainage.
Indications for dSOCs were retrieved retrospectively 
from the clinical information system (see Table 2). Most 
frequent indications were (a) indeterminate biliary stric-
tures with suspected malignancy, (b) other stenosis, for 
example, postsurgical, (c) patients with primary scle-
rosing cholangitis or secondary sclerosing cholangitis, or 
(d) biliary stones (see Table 2).
During the study period, especially in patients with 
sclerosing cholangitis, cholangioscopy was performed 
more than once if risk of malignancy was considered 
high. Further indications for a second examination dur-
ing the study period were controlled after lithotripsy to 
rule out residual stones and control of indeterminate 
stricture with negative histology to take biopsies again 
when there was still suspicion of cancer.
In 86.1% of dSOCs investigations (155/180 investiga-
tions), no complications occurred. Most frequent com-
plication is post-dSOCs cholangitis (10%; 18/180 cases), 
followed by intraductal bleeding (2.8%; 5/180 cases). For 
further details, see Table 3.
Accessibility of Targeted Structures and Technical 
Success of Digital Single-Operator Cholangioscopies
As ROI to be reached during dSOC, we defined 3 parts 
of the CBD (distal, mid, and proximal) as well as the in-
trahepatic biliary system. Accessibility of the ROI was ex-
cellent for the mid, proximal CBD, and the intrahepatic 
biliary system, whereas ROIs in the distal CBD were suc-
cessfully reached only in 84% of the cases. Also, biopsies 
were difficult to take in the distal CBD, mainly due to the 
instable position of the cholangioscope in the distal CBD 
(see Table 4).






Average age, years 64
Maximum age, years 97
Minimum age, years 7
*Percutaneous access via PTC in 4 cases.
Table 2. Indications for the cholangioscopies performed in this 
study
Indication Patients, n
Suspicion of biliary malignancy 37
Indeterminate stenosis with cholestasis 33
PSC/SSC 32
Biliary stones 34
Control after biliary intervention/follow-up 34
Others 10
PSC, primary sclerosing cholangitis; SSC, secondary sclerosing 
cholangitis.




In addition, Table 4 shows the performance of EHL or 
cholangioscopic-guided guidewire insertion of a defined 
intrahepatic bile duct. dSOC-guided guidewire place-
ment was performed when conventional ERC and deep 
cannulation failed with at least 2 different wires (straight 
and bend) within 15 min. Successful bile duct stone treat-
ment was defined as complete bile duct clearance during 
the first intervention.
Diagnostic Accuracy for Digital Single-Operator 
Cholangioscopy-Related Diagnosis for Suspicious 
Biliary Lesions
All patients with already known biliary malignancy (19 
patients) were excluded from the final analysis. Retro-
spectively, we categorized all patients based on the pre-
dSOCs clinical suspicion for malignancy: (I) no clinical 
“a-priori” suspicion (67%; 108/161 of the cases); (II) clin-
ical or radiological “a-priori” uncertainty (21%; 34/161 of 
the cases); and (III) high “a-priori” suspicion for malig-
nancy (12%, 19/161 of the cases). These data as well as the 
assessment by the investigator based on the visualization 
are shown in Figure 1. The categorization was done using 
the report of the investigator of the initial dSOC only to 
avoid bias as good as possible in this retrospective analy-
sis.
By dSOCs, we described 43 suspicious lesions. Malig-
nancy was confirmed in 27 of those cases either by chol-
angioscopic-guided biopsies, by surgical outcome, or 
during follow-up (Re-dSOC; MRI/CT; surgery). On the 
other hand, 118 cholangioscopic unsuspicious findings 
were reported, in whom only 4 cases turned out to be ma-
lignant in the follow-up. Based on that retrospective data, 
we calculated a sensitivity of 0.87 (95% CI 0.70–0.96) and 
specificity 0.88 (95% CI 0.81–0.93) as well as a PPV of 0.63 
(95% CI 0.47–0.77) and a NPV of 0.97 (95% CI 0.92–0.99) 
for the whole cohort.
We also calculated sensitivity, specificity, PPV, and 
NPV in the predefined clinical subgroups (see Fig. 1; [I] 
“no clinical a-priori suspicion”; [II] clinical or radiologi-
cal “a-priori uncertainty”; [III] “high a-priori suspicion” 
for malignancy).
For patients with “low or no clinical a-priori suspi-
cion,” (I) sensitivity and specificity were 0.5 (0.22–0.78) 
and 0.92 (0.85–0.96) with PPV of 0.34 (0.14–0.61) but 
NPV of 0.96 (0.90–0.98). In contrast, for patient with “a 
high a-priori suspicion” for malignancy (n = 19), sensitiv-
ity was 1.0 (0.82–1.00), specificity 1.0 (0.05–1.00) as well 
as PPV of 1.0 (0.82–1.00) and NPV of 1.0 (0.05–1.0) were 
high. In patients with “a-priori uncertainty” of indetermi-
nate biliary strictures (n = 34), sensitivity was 1.0 (0.61–
1.00), specificity 0.75 (0.57–0.87), PPV 0.46 (0.23–0.71), 
and a high NPV of 1.0 (0.85–1.00) for the visual diagnosis 
of biliary malignancy. For all patients (n = 53) with any 
kind of biliary lesion with suspicion for malignancy 
(“high a-priori suspicion” + “a-priori uncertainty”), sen-
sitivity was 1.0 (95% CI 0.86–1.0), specificity 0.76 (95% CI 
0.56–0.9) with a calculated PPV 0.77 (95% CI 0.59–0.9), 
and a high NPV of 1.0 (95% CI 0.85–1.0) for the visual 
diagnosis of biliary malignancy.
Table 4. Shown is the ROI that was to be investigated during 







biopsy if ROI 
was suspicious, 
n/N (%)
Distal CBD 44/180 (24) 37/44 (84) 8/13 (62)
Mid-CBD 44/180 (24) 41/44 (93) 5/6 (83)
Proximal CBD 77/180 (43) 75/77 (97) 20/21 (95)
Intrahepatic bile system 13/180 (7) 12/13 (92) 1/1 (100)






EHL 24/180 (13) 20/24 (83)
Guidewire insertion 31/180 (17) 27/31 (87)
The last row shows in how many cases the region looked 
suspicious and in how many cases biopsy could be performed. In 
the lower part of the table, the performed interventions during 
cholangioscopy and success rates of the procedure are listed. In 
case of EHL, complete stone clearance during the first intervention 
is meant. CBD, common bile duct; EHL, electrohydraulic 
lithotripsy; ROI, region of interest.
Table 3. Complications that occurred during or after the 
cholangioscopy are shown in total numbers (and percent) of the 
performed investigations











dSOC has already become standard of care and com-
plementary to ERC for biliary interventions, at least in 
specialized high-volume centers. For difficult biliary 
stones, therapeutic dSOC combined with EHL is the most 
effective endoscopic therapy [11, 16]. dSOCs have been 
demonstrated to be a safe procedure, also in elderly pa-
tients. Diagnostic accuracy of dSOC-directed biopsies is 
higher than brush cytology in obtaining a histological di-
agnosis of unclear biliary strictures and alterations [12, 
14, 20].
First studies have shown the diagnostic value of dSOCs 
imaging for evaluating indeterminate biliary strictures 
and lesions as well a proposed classification for macro-
scopic characterization of determined stenosis. On the 
other hand, dSOC has been evaluated for guidewire place-
ment into the region of interest or passing complex stric-
tures and stenoses [8, 17, 18].
Another important issue is the potential of dSOCs to 
reduce fluoroscopy time. As soon as the cholangioscope 
has been inserted in the biliary system, fluoroscopy is al-
most not needed any more. It already had been discussed 
in an Editorial if we can abandon fluoroscopy in the fu-
ture [21]. We still relay on fluoroscopy during dSOC; 
however, the fluoroscopy time is markedly reduced using 
dSOC (data were not evaluated in this retrospective 
study).
In our large study with 180 investigations in 117 pa-
tients, we confirm the procedural safety profile of dSOC 
procedures. No major complication occurred. The most 
common complications were cholangitis in 10% and mild 
bleeding in <3% of the patients. The potential risk of chol-
angitis can further be reduced by applying peri-interven-
tional antibiotic prophylaxis in all patients. Antibiotic 
prophylaxis has not been applied in our patient cohort in 
a standardized manner, but only in those patients with 
other reasons (preexisting cholangitis and dilation). 
However, our complication rate was rather low compared 
to earlier studies [12], even in our study population being 
rather ill, with high comorbidities or under immunosup-
pressive therapy in some cases. Unfortunately, our data 
do not allow to compare the risk of cholangitis in the pop-
ulation with or without antibiotic treatment. However, as 
procedural result of the study, we changed our protocol 
and perform peri-interventional antibiotic prophylaxis in 
all patients undergoing dSOC.
Almost all ROIs in the middle or upper CBD and the 
primary and secondary intrahepatic, ducts were success-
fully reached in our cohort. Biopsies were obtained if nec-
essary. However, we clearly show that for the distal CBD, 












Clinical or radiological uncertainty/“maybe”
34/161 (21%)
Digital, single-operator cholangioscopy (dSOC)
Clinical suspicious for bilary stenosis/lesion before dSOC?
180 dSOCS












Fig. 1. Shown are the performed dSOCs of this study, the clinically suspected finding before cholangioscopy as 
well as the assessment of the investigator after dSOC based on the visualized impression. dSOC, digital single-
operator cholangioscopy.




ity of the ROI, which was successful in only two-thirds of 
the patients. Due to the instable position in the distal 
CBD, biopsies were even more difficult to obtain in those 
patients.
In cases with difficult cannulation, cholangioscopic-
guided guidewire cannulation is a proper option. This 
was efficient in all patients were standard guidewire can-
nulation failed repeatedly under fluoroscopic guidance.
A main focus of our study was to evaluate the diagnos-
tic accuracy of the dSOCs imaging and visualization of 
biliary lesions and indeterminate strictures. The endo-
scopic imaging and macroscopic characterization of the 
investigator were compared with histology (or surgery) 
and follow-up of the patients. This is a remarkable 
strength of our study that a final diagnosis was obtained 
and therefore positive and NPV could be calculated ade-
quately. We found an extremely high NPV of 0.97 in the 
whole study cohort. Therefore, the visual criteria to rule 
out a malignancy can be gathered very well by dSOC, at 
least by experienced investigators. In focus of the clinical 
reality with additional imaging modalities and patients’ 
history, we defined different clinical scenarios with differ-
ent a-priori likelihood of an expected malignant stenosis. 
In patients with high a-priori likelihood, dSOC with mac-
roscopic characterization of undetermined strictures re-
vealed a very high test accuracy. In those patients with any 
biliary lesion (“high a-prioriy suspiscion” and “a-priori 
uncertainty”), sensitivity and specificity were 1.0 (95% CI 
0.86–1.0) and 0.76 (95% CI 0.56–0.9) with a calculated 
PPV 0.77 (95% CI 0.59–0.9) and a high NPV of 1.0 (95% 
CI 0.85–1.0) for the visual diagnosis of biliary malig-
nancy.
Even in cases with negative biopsies, these results en-
courage the use of dSOC in the diagnostic and manage-
ment of biliary malignancy. Especially, in case of border-
line resectable tumors with expected large surgical extend 
and associated mortality, dSOC enables endoscopists and 
surgeons to ensure the clinical management when dis-
cussing demanding surgical resection. In patients with a 
“borderline” a-priori likelihood, the NPV is still very high 
to ensure a further follow-up of an indeterminate biliary 
strictures.
The PPV with 0.77 to define a malignant transforma-
tion within the biliary system is higher than histology or 
brush cytology [14] but still needs to be improved. Most 
common benign strictures that were misdiagnosed as 
malignant were inflammatory strictures. Another advan-
tage of dSOC is that the expansion of biliary lesions can 
much better be evaluated than in the fluoroscopy. In-
tramucosal changes are not apparent using X-ray only. 
However, the more important point, in clinical practice 
when discussing the potential malignant pathogenesis of 
a biliary lesion or stenosis, is a reliable high NPV of dSOC-
based visualization that helps for decision-making and 
leading the patients’ further therapeutic options with 
more confidence.
Taken together, dSOC is a highly efficient method to 
evaluate indeterminate biliary lesions, stenoses, and stric-
tures. In determinant biliary stenosis, accuracy of digital 
endoscopic biliary imaging by dSOC is quite high, with a 
remarkable NPV. If this finding is reproducible, dSOC 
possibly will be included in a standardized diagnostic and 
therapeutic procedure in patients with biliary lesions sus-
pected for cholangiocarcinoma. Prospective, multicenter 
studies to confirm these data are already recruiting pa-
tients. In addition, our data confirm the high safety and 
technical efficacy of this new method. We believe adding 
dSOC in most ERCP procedures will become standard of 
care in the near future.
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